Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00025818 | Six Month Clinical Research Study for Patients With Moderate or Severe Dry Eye Syndrome | PHASE3 | COMPLETED | 290 | — | — | May 1, 2001 | Mar 1, 2003 | May 30, 2011 | 17 | United States |
| Name | Type | Description |
|---|---|---|
| Ophthalmic Emulsion | DRUG | - |
* Eighteen years or older * Diagnosis of moderate to severe dry eyes for at least 6 months and meet one or all of the following criteria: * Diagnosis of autoimmune disorder * Female 65 years of age or older